SOGEN INTERNATIONAL FUND, INC.
1221 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10020
(800) 334-2143
------------------
NOTICE OF MEETING OF SHAREHOLDERS
April 17, 1996
------------------
To the Shareholders of SOGEN INTERNATIONAL FUND, INC.:
NOTICE IS HEREBY GIVEN that a Meeting of Shareholders (the "Meeting") of
SoGen International Fund, Inc. (the "Fund") will be held at the offices of the
Fund, 1221 Avenue of the Americas, 8th Floor, New York, New York 10020, on April
17, 1996 at 9:00 a.m., for the following purposes, all of which are more fully
described in the accompanying Proxy Statement dated February 27, 1996.
1. To elect five Directors, each to hold office for an indefinite
period of time and until his successor is duly elected and qualified;
2. To ratify or reject the selection of KPMG Peat Marwick LLP as
independent certified public accountants of the Fund for its fiscal year
ending March 31, 1996;
3. To approve or disapprove a proposal to eliminate the fundamental
investment policy of the Fund prohibiting investments in other investment
companies;
4. To approve or disapprove a proposal to amend the fundamental
investment policy of the Fund prohibiting the making of loans (other than
through the purchase of publicly distributed debt securities) to permit
investments in privately placed debt securities and securities lending; and
5. To transact such other business as may properly come before the
Meeting or any adjournment thereof.
The Directors have fixed the close of business on February 23, 1996 as
the record date for the determination of shareholders entitled to notice of
and to vote at the Meeting or any adjournment thereof. The enclosed proxy is
being solicited on behalf of the Directors.
By order of the Board of Directors,
Philip J. Bafundo
Secretary
New York, New York
February 27, 1996
===============================================================================
YOUR VOTE IS IMPORTANT
PLEASE INDICATE YOUR VOTING INSTRUCTIONS ON THE ENCLOSED PROXY CARD,
SIGN AND DATE IT, AND RETURN IT IN THE ENVELOPE PROVIDED, WHICH NEEDS NO
POSTAGE IF MAILED IN THE UNITED STATES. IN ORDER TO SAVE THE FUND ANY
ADDITIONAL EXPENSE OF FURTHER SOLICITATION, PLEASE MAIL YOUR PROXY
PROMPTLY.
===============================================================================
<PAGE>
PROXY STATEMENT
TABLE OF CONTENTS
Page
Introduction................................................................1
Certain Information Regarding the Investment Adviser,
the Principal Underwriter, the Accounting Agent
and the Shareholder Servicing Agent.......................................2
Proposal One: Election of Directors........................................2
Proposal Two: Ratification or Rejection of
Selection of Independent Certified
Public Accountants .......................................................5
Proposal Three: Approval or Disapproval of
the Proposal to Eliminate the Fundamental
Investment Policy of the Fund Prohibiting
Investments in Other Investment Companies.................................5
Proposal Four: Approval or Disapproval of the
Proposal to Amend the Fundamental Investment
Policy of the Fund Prohibiting the Making of
Loans (Other than Through the Purchase of
Publicly Distributed Debt Securities) to Permit
Investments in Privately Placed Debt Securities
and Securities Lending....................................................6
Officers of the Fund........................................................8
Other Matters...............................................................8
Votes Required .............................................................9
- i -
<PAGE>
PROXY STATEMENT
SOGEN INTERNATIONAL FUND, INC.
1221 AVENUE OF THE AMERICAS
NEW YORK, NEW YORK 10020
(800) 334-2143
------------------
MEETING OF SHAREHOLDERS
APRIL 17, 1996
------------------
INTRODUCTION
This Proxy Statement is furnished in connection with the solicitation of
proxies on behalf of the Board of Directors of SoGen International Fund, Inc., a
Maryland corporation (the "Fund"), to be voted at a Meeting of Shareholders of
the Fund, to be held at the offices of the Fund, 1221 Avenue of the Americas,
8th Floor, New York, New York 10020, on April 17, 1996 at 9:00 a.m., and at any
adjournments thereof (collectively, the "Meeting"). Such solicitation will be by
mail and the cost (including printing and mailing this Proxy Statement, meeting
notice and form of proxy, as well as any necessary supplementary solicitation)
will be borne by the Fund. The Notice of Meeting, Proxy Statement and Proxy are
being mailed to shareholders on or about February 27, 1996.
The presence in person or by proxy of the holders of record of one-third
of the shares of the Fund entitled to vote thereat shall constitute a quorum at
the Meeting. If, however, such quorum shall not be present or represented at the
Meeting or if fewer shares are present in person or by proxy than is the minimum
required to take action with respect to any proposal presented at the Meeting,
the holders of a majority of the shares of the Fund present in person or by
proxy shall have the power to adjourn the Meeting from time to time, without
notice other than announcement at the Meeting, until the requisite amount of
shares entitled to vote at the Meeting shall be present. At any such adjourned
Meeting, if the relevant quorum is subsequently constituted, any business may be
transacted which might have been transacted at the Meeting as originally called.
For purposes of determining the presence of a quorum for transacting business at
the Meeting, abstentions and broker "non-votes" (that is, proxies from brokers
or nominees indicating that such persons have not received instructions from the
beneficial owner or other persons entitled to vote shares on a particular matter
with respect to which the brokers or nominees do not have discretionary power)
will be treated as shares that are present but which have not been voted. For
this reason, abstentions and broker non-votes will have the effect of a "no"
vote for purposes of obtaining the requisite approval of each proposal.
The Board of Directors has fixed the close of business on February 23,
1996 as the record date for the determination of shareholders entitled to notice
of and to vote at the Meeting and at any adjournments thereof. The outstanding
voting shares of the Fund as of February 16, 1996 consisted of shares of common
stock, each share being entitled to one vote. All properly executed proxies
received prior to the Meeting will be voted at the Meeting in accordance with
the instructions marked thereon or as otherwise provided therein. Accordingly,
unless instructions to the contrary are marked, proxies will be voted for the
matters specified on the proxy card. Any shareholder may revoke his proxy at any
time prior to exercise thereof by giving written notice to the Secretary of the
Fund at its offices at 1221 Avenue of the Americas, New York, New York 10020, or
by signing another proxy of a later date, or by personally casting his vote at
the Meeting.
<PAGE>
The most recent annual and semi-annual reports of the Fund, including
financial statements, have been previously mailed to shareholders. If you have
not received these reports or would like to receive additional copies free of
charge, please contact the Fund at 1221 Avenue of the Americas, New York, New
York 10020, (800) 334-2143 and they will be sent promptly by first-class mail.
CERTAIN INFORMATION REGARDING
THE INVESTMENT ADVISER, THE PRINCIPAL UNDERWRITER,
THE ACCOUNTING AGENT AND THE SHAREHOLDER SERVICING AGENT
The Fund has retained Societe Generale Asset Management Corp. ("SOGEN A.M.
Corp."), a Delaware corporation, with offices at 1221 Avenue of the Americas,
New York, New York 10020, to serve as its investment adviser (the "Adviser")
under an investment advisory agreement which became effective April 26, 1990.
The Adviser is an indirect, majority-owned subsidiary of Societe Generale, which
is one of France's largest banks. The Fund has retained the services of Societe
Generale Securities Corporation ("SGSC"), with offices at 1221 Avenue of the
Americas, New York, New York 10020, to serve as its principal underwriter.
Investors Fiduciary Trust Company, 127 West 10th Street, Kansas City, Missouri
64105 serves as accounting agent to the Fund and The Shareholder Services Group,
P.O. Box 9123, Boston, Massachusetts 02209-9123 serves as shareholder servicing
agent to the Fund.
PROPOSAL ONE
ELECTION OF DIRECTORS
At the Meeting, five Directors will be elected to serve, each for an
indefinite period of time and until his successor is duly elected and qualified.
The nominees are Jean-Marie Eveillard, Fred J. Meyer, Dominique Raillard, Nathan
Snyder and Philippe Collas. It is the intention of the persons named in the
enclosed proxy to nominate and vote in favor of the nominees.
Each of the nominees has consented to serve as a Director. All the
nominees are currently Directors of the Fund except for Philippe Collas. The
Board of Directors of the Fund knows of no reason why any of the nominees would
be unable to serve, but in the event of such unavailability, the proxies
received will be voted for such substitute nominees as the Board of Directors
may recommend.
- 2 -
<PAGE>
Certain information concerning the current Directors of the Fund and the
nominees is set forth below:
<TABLE>
<CAPTION>
Approximate
Number
of Shares
Year Beneficially Owned
Name, Positions and Offices with the Fund, First Year Term Directly or
Age, Principal Occupations During Became a as Director Indirectly as of
the Past Five Years and Other Directorships Director Will Expire February 16, 1996
- ------------------------------------------- -------- ----------- -----------------
<S> <C> <C>
Jean-Pierre Gentil*+.................................................. 19 1996
Chairman of the Board and Director of the Fund, age 56; Manager of
the Property and Casualty Insurance Division of Societe Generale since
December 1995; Manager of the Investment and Custody Department
of Societe Generale from prior to 1991 to 1995; Director of SGSC.
Mr. Gentil's address is 50, boulevard Haussman, 75009 Paris, France.
Jean-Marie Eveillard*(1).............................................. 19 Indefinite
Director and President of the Fund, age 56; Director and President of
SoGen Funds, Inc.; Director and President or Executive Vice President
of SOGEN A.M. Corp. from prior to 1991; owner of non-voting
shares of the Adviser's common stock. Mr. Eveillard's address is 1221
Avenue of the Americas, New York, New York.
Fred J. Meyer(2)...................................................... 19 Indefinite
Director of the Fund, age 65; Director of SoGen Funds, Inc.; Chief
Financial Officer of Omnicom Group Inc. from prior to 1991. Mr.
Meyer's address is 437 Madison Avenue, New York, New York.
Dominique Raillard(2)................................................. 19 Indefinite
Director of the Fund, age 57; Director of SoGen Funds, Inc.; President
of Act 2 International (consulting) since July 1995; Group Executive
Vice President of Promodes (consumer products) - U.S. Companies
Division from prior to 1991 to 1995. Mr. Raillard's address is 15,
boulevard Delessert, 75016 Paris, France.
Nathan Snyder(1)(2)................................................... 19 Indefinite
Director of the Fund, age 61; Director of SoGen Funds, Inc.;
Independent Consultant from prior to 1991. Mr. Snyder's address is
163 Parish Road South, New Canaan, CT 06840.
Philippe Collas....................................................... 1996++ Indefinite
Nominee for Director of the Fund, age 46; Head of Asset Management
at Societe Generale since September 1995; Head of Human Resource
Management at Societe Generale from September 1991 to 1995; Chief
Executive Officer of Societe Generale Capital Markets (London) from
prior to 1991; Chairman of the Board and Director of SoGen Funds,
Inc. and SOGEN A.M. Corp. Mr. Collas' address is 17, cours Valmy,
92972 Paris, France.
<FN>
- ------------------
* "Interested person," as defined in the Investment Company Act of 1940, of
the Fund because of the affiliation with SOGEN A.M. Corp., the Fund's
investment adviser, or with Societe Generale, SOGEN A.M. Corp's parent.
(1) Member of the Executive Committee. When the Board of Directors is not in
session, the Executive Committee may generally exercise most of the powers
of the Board of Directors.
(2) Member of the Audit Committee.
+ Resigned from the Board effective upon the election of Mr. Collas as his
successor.
++ If elected at the Meeting.
</FN>
</TABLE>
- 3 -
<PAGE>
------------------
During the Fund's fiscal year ended March 31, 1995, the Board of Directors
met four times. Each of the Fund's Directors attended at least 75% of the
meetings of the Board of Directors and of all the committees of the Board on
which he served except for Mr. Gentil, who attended 50% of such meetings. The
Fund maintains an Audit Committee of the Board of Directors, which is composed
of all the Directors who are not "interested persons" of the Fund within the
meaning of the Investment Company Act of 1940 (the "1940 Act"). The Audit
Committee met twice during the fiscal year ended March 31, 1995 for the purposes
described below under "Proposal Two: Ratification or Rejection of Selection of
Independent Certified Public Accountants." Directors of the Fund who are not
interested persons of the Fund are paid an annual retainer of $6,000 and a fee
of $1,000 for each meeting of the Fund's Board of Directors and for each meeting
of any committee of the Board attended (other than those held by telephone
conference call). Each Director is reimbursed by the Fund for any expenses he
may incur by reason of attending such meetings or in connection with services he
may perform for the Fund.
As of February 16, 1996 the Directors and officers of the Fund as a group
owned less than 1% of the shares of the Fund. The Fund knows of no person who
owns beneficially more than 5% of the capital stock of the Fund.
Compensation of Directors and Certain Officers. The following table sets
forth information regarding compensation of Directors by the Fund and by the
fund complex of which the Fund is a part for the fiscal year ended March 31,
1995. Officers of the Fund and Directors who are interested persons of the Fund
do not receive any compensation from the Fund or any other fund in the fund
complex. In the column headed "Total Compensation From Registrant and Fund
Complex Paid to Directors," the number in parentheses indicates the total number
of boards in the fund complex on which the director serves.
<TABLE>
<CAPTION>
Compensation Table
Fiscal Year Ended March 31, 1995
Pension or Total
Retirement Compensation
Benefits Estimated From
Aggregate Accrued Annual Registrant
Compensation As Partof Benefits and Fund
from Fund Upon Complex Paid
Names of Person, Position Registrant Expenses Retirement to Directors
- ------------------------- ---------- -------- ---------- ------------
<S> <C> <C> <C> <C>
Jean-Pierre Gentil**+, Director and Chairman.... $ -- N/A N/A $ -- (2)
Jean-Marie Eveillard**, Director and President.. $ -- N/A N/A $ -- (2)
Fred J. Meyer*, Director........................ $6,600 N/A N/A $12,600(2)
Dominique Raillard*, Director................... $8,100 N/A N/A $16,455(2)
Nathan Snyder*, Director........................ $8,700 N/A N/A $16,800(2)
<FN>
- -----------
* Member of the Audit Committee.
** "Interested person" of the Company as defined in the 1940 Act because of the
affiliation with SOGEN A.M. Corp., the Fund's investment adviser, or with
Societe Generale, SOGEN A.M. Corp.'s parent.
+ Resigned from the Board effective upon the election of Mr. Collas as his
successor.
</FN>
</TABLE>
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS OF THE FUND VOTE
FOR THE ELECTION OF THE NOMINEES TO SERVE AS DIRECTORS OF THE FUND.
- 4 -
<PAGE>
PROPOSAL TWO
RATIFICATION OR REJECTION OF SELECTION OF
INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
The Board of Directors recommends that the shareholders of the Fund ratify
the selection of KPMG Peat Marwick LLP, independent certified public
accountants, to audit the accounts of the Fund for the fiscal year ending March
31, 1996. Their selection was approved by the unanimous vote, cast in person, of
the Directors of the Fund, including the Directors who are not "interested
persons" of the Fund within the meaning of the 1940 Act, at a meeting held on
April 7, 1995. KPMG Peat Marwick LLP has audited the accounts of the Fund since
the fiscal year ended March 31, 1990 and does not have any direct financial
interest or any material indirect financial interest in the Fund. A
representative of KPMG Peat Marwick LLP is expected to attend the Meeting and to
have the opportunity to make a statement and respond to appropriate questions
from the shareholders. The Audit Committee of the Board of Directors meets twice
each year with representatives of KPMG Peat Marwick LLP to discuss the scope of
their engagement and review the financial statements of the Fund and the results
of their examination thereof.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS OF THE FUND VOTE
FOR THE RATIFICATION OF THE SELECTION OF KPMG PEAT MARWICK LLP AS INDEPENDENT
CERTIFIED PUBLIC ACCOUNTANTS OF THE FUND.
PROPOSAL THREE
APPROVAL OR DISAPPROVAL OF THE PROPOSAL TO ELIMINATE
THE FUNDAMENTAL INVESTMENT POLICY OF
THE FUND PROHIBITING INVESTMENTS IN OTHER INVESTMENT COMPANIES
Currently, the Fund's fundamental investment policies provide that the
Fund may not invest in securities of other investment companies. If the proposed
elimination of this restriction is approved, the Fund's investment policies will
be revised to permit investment in the securities of other investment companies
within the limits prescribed by the 1940 Act.
Section 12(d)(1)(A) of the 1940 Act prohibits an investment company from
acquiring more than 3% of the outstanding voting securities of another
investment company. That section also prohibits a registered investment company
from acquiring shares of another investment company if, immediately after the
proposed acquisition of shares, either (a) the acquiring company would own
securities of the acquired company with a value of more than 5% of the total
assets of the acquiring company, or (b) the acquiring company would own
securities of investment companies with an aggregate value of more than 10% of
its total assets. Section 12(d) provides for certain limited exceptions to these
restrictions. Investment in another investment company may involve the payment
of a premium above the value of the issuer's portfolio securities, and is
subject to market availability. In the case of a purchase of shares of such a
company in a public offering, the purchase price may include an underwriting
spread. The Fund does not intend to invest in such an investment company unless,
in the judgment of the Adviser, the potential benefits of such investment
justify the payment of any applicable premium or sales charge. As a shareholder
in another investment company, the Fund would bear its ratable share of that
investment company's expenses, including its advisory and administration fees.
At the same time, the Fund would continue to pay its own management fees and
other expenses.
- 5 -
<PAGE>
SOGEN A.M. Corp. and the Board of Directors believe that it would be
desirable for the Fund to have the flexibility to invest in other investment
companies. If this proposal is adopted, the Fund will be able to invest in other
investment companies, within the limits prescribed by the 1940 Act as set forth
above. SOGEN A.M. Corp. believes that the ability to invest in other investment
companies could enhance the Fund's ability to achieve its investment objective.
The Fund invests its assets in the securities markets of numerous countries
around the world. In certain markets, direct access by foreign investors (such
as the Fund) may be prohibited or restricted, in which case investment through
another investment company may be the sole means by which the Fund could gain
market exposure in a particular country. Investing in foreign markets via other
investment companies may be deemed desirable for other reasons as well (for
example, to avoid prohibitive transactional or custodial costs).
The Board of Directors believes that the proposed elimination of this
fundamental investment policy of the Fund is in the best interests of the Fund
and its shareholders, and recommends that shareholders vote FOR the proposal. If
the proposal is not approved by the Fund's shareholders, the Fund's fundamental
investment policies will continue to prohibit investments in other investment
companies.
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS OF THE FUND VOTE
FOR THE ELIMINATION OF THIS FUNDAMENTAL INVESTMENT POLICY.
PROPOSAL FOUR
APPROVAL OR DISAPPROVAL OF THE PROPOSAL TO AMEND
THE FUNDAMENTAL INVESTMENT POLICY OF THE FUND
PROHIBITING THE MAKING OF LOANS (OTHER THAN
THROUGH THE PURCHASE OF PUBLICLY DISTRIBUTED DEBT
SECURITIES) TO PERMIT INVESTMENTS IN PRIVATELY PLACED
DEBT SECURITIES AND SECURITIES LENDING
Currently, the Fund's fundamental investment policies provide that the
Fund may not make loans other than through the purchase of publicly distributed
debt securities such as notes, bonds and debentures. Shareholders are being
asked to approve an amendment to this restriction to permit the Fund to invest a
portion of its assets in certain privately placed debt securities and to lend
its portfolio securities, which amendment is described below.
(a) Investment in Privately Placed Debt Securities. If the proposed
amendment is adopted, the Fund will be able to invest up to an aggregate of 15%
of its total assets in debt obligations of the type that are privately placed
with financial institutions. In the past, purchasers of privately placed
securities normally had difficulty in disposing of such securities because the
securities are not registered for sale under the Securities Act of 1933 (the
"1933 Act"). Such securities generally can be sold only in privately negotiated
transactions or in a public offering with respect to which a registration
statement is in effect under the 1933 Act. When registration is required, the
seller might be obligated to pay all or part of the registration expenses. In
either case, a period of time may elapse between the time of the decision to
sell and the time the seller may be able to negotiate a sale in a private
transaction or sell a security under an effective registration statement, as a
result of which, if adverse market conditions were to develop, the seller could
receive a less favorable price. In addition, securities for which there is not
an established trading market may be difficult to value.
However, recently adopted Rule 144A under the 1933 Act now permits certain
qualified institutional buyers such as the Fund to trade in privately placed
securities that have not been registered under the 1933 Act. As a result,
trading markets have developed among financial institutions for some privately
placed securities. If
- 6 -
<PAGE>
the proposed amendment to the Fund's investment restrictions is adopted, the
Fund will have the ability to participate in such markets. The Fund's separate
investment policy limiting its investment in illiquid assets to 10% of the value
of its net assets will still be applicable. (This policy regarding illiquid
investments may be changed by the Board of Directors without the vote of the
Fund's shareholders; however, the Securities and Exchange Commission currently
requires registered investment companies to limit their investment in illiquid
securities to 15% of net assets.) Accordingly, the Fund's Board of Directors
will be required to make a determination with respect to each privately placed
security purchased by the Fund as to whether such security is liquid or
illiquid; those securities that the Board deems to be illiquid may be purchased
by the Fund but will be subject to the 10% limitation described above as well as
the risks referred to in the preceding paragraph.
(b) Securities Lending. If the Fund adopts the proposed change to its
investment policies, the Fund will be permitted to loan to banks and
broker-dealers portfolio securities with an aggregate market value of up to 33%
of its total assets when the Fund's investment adviser deems it advisable. The
practice of loaning portfolio securities has become a frequently employed
portfolio management technique in the past several years. The Fund's Board of
Directors believes that adoption of the proposed amendment would result in added
flexibility to the Fund's portfolio management practices, by enabling the Fund
to enhance the income earned on its investment portfolio, in a manner that would
be consistent with the Fund's investment objective of providing long-term growth
of capital.
If the amendment is adopted, any loans of the Fund's portfolio securities
would be required to be secured by collateral (consisting of any combination of
cash, U.S. Government securities, irrevocable letters of credit or other
high-quality debt securities) in an amount at least equal (on a daily
marked-to-market basis) to the current market value of the securities loaned and
the Fund would be permitted to retain a portion of the income earned on such
collateral. The Fund would be able to terminate the loans at any time and obtain
the return of the securities. The Fund would continue to receive any interest or
dividends paid on the loaned securities and would continue to have voting rights
with respect to the securities. In connection with the lending of its portfolio
securities, the Fund would be exposed to the risk of delay in recovery of the
securities loaned or possible loss of right in the collateral should the
borrower become insolvent. The Fund may pay fees to other persons for arranging
securities loans.
(c) Text of Proposed Amendment. The proposed modification would amend
and restate Paragraph 7 of the Fund's fundamental investment restrictions to
read as follows:
7. It may not make loans, but this restriction shall not
prevent the Fund from (a) buying a part of an issue of bonds,
debentures, or other obligations that are publicly distributed,
or from investing up to an aggregate of 15% of its total assets
(taken at market value at the time of each purchase) in parts
of issues of bonds, debentures or other obligations of a type
privately placed with financial institutions or (b) lending
portfolio securities, provided that the Fund may not lend
securities if, as a result, the aggregate value of all
securities loaned would exceed 33% of its total assets
(taken at market value at the time of such loan).
The Board of Directors believes that the proposed amendment to the Fund's
fundamental investment policy relating to the making of loans to permit
investments in privately placed debt securities and securities lending is in the
best interests of the Fund and its shareholders, and recommends that
shareholders vote FOR the proposal. If the proposal is not approved by the
Fund's shareholders, the Fund's fundamental investment policies will continue to
prohibit the making of loans other than through the purchase of publicly
distributed debt securities.
- 7 -
<PAGE>
THE BOARD OF DIRECTORS RECOMMENDS THAT THE SHAREHOLDERS OF THE FUND VOTE
FOR THE AMENDMENT OF THIS FUNDAMENTAL INVESTMENT POLICY.
OFFICERS OF THE FUND
The principal officers of the Fund and their principal occupations during
the past five years are set forth below. The address of each such officer (other
than Mr. Gentil) is 1221 Avenue of the Americas, New York, New York 10020.
Jean-Pierre Gentil is Chairman of the Fund's Board. Biographical
information regarding Mr. Gentil is set forth above under "Proposal One:
Election of Directors."
Jean-Marie Eveillard is President of the Fund. Biographical information
regarding Mr. Eveillard is set forth above under "Proposal One: Election of
Directors."
Philip J. Bafundo, age 33, is Vice President, Secretary and Treasurer of
the Fund. He has been Secretary and Treasurer of SOGEN A.M. Corp. since
January 1991.
Ignatius Chithelen, age 41, is Vice President of the Fund, and has been
a securities analyst at SOGEN A.M. Corp. since October 1993. He was a reporter
at Forbes from prior to 1991 to October 1993.
Catherine A. Shaffer, age 40, a Vice President of the Fund, has been First
Vice President of SGSC since January 1991.
Edwin S. Olsen, age 56, a Vice President of the Fund, has also been a Vice
President of SGSC since prior to 1991.
Elizabeth Tobin, age 42, is a Vice President and Assistant Secretary of
the Fund. She has been a securities analyst with SOGEN A.M. Corp. and with
SGSC since prior to 1991.
Charles de Vaulx, age 34, is a Vice President of the Fund and has also
been a securities analyst with each of SOGEN A.M. Corp. and SGSC since prior
to 1991.
OTHER MATTERS
Management does not know of any matters to be presented at the Meeting
other than those mentioned in this Proxy Statement. If any of the persons listed
above is unavailable for election as a Director, an event not now anticipated,
or if any other matters properly come before the Meeting, the shares represented
by proxies will be voted with respect thereto in accordance with the best
judgment of the person or persons voting the proxies.
If the accompanying form of proxy is executed properly and returned,
shares represented by it will be voted at the Meeting in accordance with the
instructions on the proxy. However, if no instructions are specified, shares
will be voted for the election of the Director and for the other proposals.
- 8 -
<PAGE>
VOTES REQUIRED
The presence in person or by proxy of the holders of one-third of the
outstanding shares is required to constitute a quorum at the Meeting. The
election of Directors, as set forth in Proposal One, will require, with respect
to each nominee, a vote of the holders of a plurality of the Fund's shares
present at the Meeting. Ratification of the selection of the independent
certified public accountants, as set forth in Proposal Two, will require a vote
of the holders of a majority of the Fund's shares present at the Meeting. The
elimination of the Fund's fundamental investment policy prohibiting investments
in other investment companies, as set forth in Proposal Three, will require a
majority vote of the Fund's outstanding voting securities (defined in the 1940
Act as (a) 67% or more of the voting securities present at a meeting of
shareholders, if the holders of more than 50% of the outstanding voting
securities of such company are present or represented by proxy, or (b) more than
50% of the outstanding voting securities of such company, whichever is less).
The amendment of the Fund's fundamental investment policy prohibiting the making
of loans to permit investments in privately placed debt securities and
securities lending, as set forth in Proposal Four, will require a majority vote
of the outstanding voting securities of the Fund (as so defined).
By order of the Board of Directors,
PHILIP J. BAFUNDO
Secretary
February 27, 1996
New York, New York
- 9 -
<PAGE>
(Please Detach at Perforation Before Mailing)
...............................................................................
SOGEN INTERNATIONAL FUND, INC. PROXY SOLICITED BY THE BOARD OF DIRECTORS
The undersigned, holder of shares of SoGen International Fund, Inc. (the
"Fund"), hereby appoints Jean-Marie Eveillard, Philip J. Bafundo and Elizabeth
Tobin, and each of them, attorneys and proxies for the undersigned with full
powers of substitution and revocation, to represent the undersigned and to vote
on behalf of the undersigned all shares of the Fund that the undersigned is
entitled to vote at the Meeting of Shareholders of the Fund to be held at the
offices of the Fund, 1221 Avenue of the Americas, 8th Floor, New York, New York
10020 on April 17, 1996 at 9:00 a.m. and any adjournment or adjournments
thereof. The undersigned hereby acknowledges receipt of the Notice of Meeting
and Proxy Statement dated February 27, 1996 and hereby instructs said attorneys
and proxies to vote said shares as indicated hereon. In their discretion, the
proxies are authorized to vote upon such other business as may properly come
before the Meeting. A majority of the proxies present and acting at the Meeting
in person or by substitute (or, if only one shall be so present, than that one)
shall have and may exercise all of the power and authority of said proxies
hereunder. The undersigned hereby revokes any proxy previously given.
NOTE: PLEASE SIGN, DATE AND RETURN
PROMPTLY IN THE ENCLOSED ENVELOPE
Date:_______________________
NOTE: Please sign exactly as your name
appears on this Proxy. If joint owners,
EITHER may sign this Proxy. When signing
as attorney, executor, administrator,
trustee, guardian or corporate officer,
please give your full title.
-----------------------------------------
-----------------------------------------
Signature(s) (Title(s), if applicable) SOG
SOGEN INTERNATIONAL FUND, INC. (SOGENF)
ORIGINAL FRONT 2-8-96
<PAGE>
<TABLE>
<CAPTION>
VOTE THIS PROXY CARD TODAY!
YOUR PROMPT RESPONSE WILL SAVE
THE EXPENSE OF ADDITIONAL MAILINGS.
(Please Detach at Perforation Before Mailing)
...............................................................................
Please vote by filing in the appropriate box below, as shown, using blue or
black ink or dark pencil. Do not use red ink. o This proxy, if properly
executed, will be voted in the manner directed by the undersigned shareholder.
IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED FOR EACH OF THE PROPOSALS.
<S> <C> <C>
1. To elect five Directors, each to hold office for an indefinite period of FOR all nominees WITHHOLD
time and until his successor is duly elected and qualified; listed (except as AUTHORITY
marked to the to vote for all
Jean-Marie Eveillard, Fred J. Meyer, Dominique Raillard, Nathan Snyder, contrary below) nominees listed
Phillippe Collas.
(INSTRUCTION: To withhold authority to vote for any individual, write |_| |_|
his name on the line provided below.)
----------------------------------------------------------------------------
</TABLE>
<TABLE>
<CAPTION>
FOR AGAINST ABSTAIN
<S> <C> <C> <C>
2. To ratify the selection of KPMG Peat Marwick LLP as independent certified
public accountants of the Fund for its fiscal year ending March 31, 1996; |_| |_| |_|
3. To approve a proposal to eliminate the fundamental investment policy of the
Fund prohibiting investments in other investment companies; |_| |_| |_|
4. To approve a proposal to amend the fundamental investment policy of the Fund
prohibiting the making of loans (other than through the purchase of publicly
distributed debt securities) to permit investments in privately placed debt
securities and securities lending; and |_| |_| |_|
5. To transact such other business as may properly come before the meeting.
</TABLE>
SOGEN INTERNATIONAL FUND, INC. (SOGENB)
ORIGINAL BACK 2-8-96
<PAGE>
